Overview of Bioavailability and Bioequivalence Guidelines for Nasal Spray and Nasal Aerosoles as per USFDA (Record no. 103753)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00713ngm a22001697a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20170601152808.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160718b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.4 |
| Item number | JAD |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Jadav, Radhika |
| 9 (RLIN) | 5121 |
| 245 ## - TITLE STATEMENT | |
| Title | Overview of Bioavailability and Bioequivalence Guidelines for Nasal Spray and Nasal Aerosoles as per USFDA |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Ahmedabad |
| Name of publisher, distributor, etc. | Institute of Pharmacy, Nirma University |
| Date of publication, distribution, etc. | 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 52p. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="ftp://10.1.15.150/B.Pharm%20Project/2016%20B.Pharm%20Project/PPR00647-Overview%20of%20Bioavailability%20and%20Bioequivalence%20Guidelines%20for%20Nasal%20Spray%20and%20Nasal%20Aerosoles%20as%20per%20USFDA-12BPH047.pdf">ftp://10.1.15.150/B.Pharm%20Project/2016%20B.Pharm%20Project/PPR00647-Overview%20of%20Bioavailability%20and%20Bioequivalence%20Guidelines%20for%20Nasal%20Spray%20and%20Nasal%20Aerosoles%20as%20per%20USFDA-12BPH047.pdf</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Project Report |
No items available.